Ignite Creation Date:
2025-12-25 @ 4:14 AM
Ignite Modification Date:
2026-01-13 @ 5:49 PM
Study NCT ID:
NCT02867020
Status:
COMPLETED
Last Update Posted:
2021-07-07
First Post:
2016-08-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Study of Abiraterone Acetate Plus ADT Versus APALUTAMIDE Versus Abiraterone and APALUTAMIDE in Patients With Advanced Prostate Cancer With Non-castrate Testosterone Levels
Sponsor:
Latin American Cooperative Oncology Group
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2017-10-11
Start Date Type:
ACTUAL
Primary Completion Date:
2019-10-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-06-30
Completion Date Type:
ACTUAL
First Submit Date:
2016-08-08
First Submit QC Date:
None
Study First Post Date:
2016-08-15
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-07-05
Last Update Post Date:
2021-07-07
Last Update Post Date Type:
ACTUAL